NCT07064226Recruiting
Validation of a Digital Intervention to Rehabilitate Cognitive Resources
Transcultural and Multidimensional Validation of dIgital Rehabilitation Intervention of COgnitive Resources Domain-Oriented - Work Package 4
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if the use of a digital cognitive rehabilitation system named RICORDO, that is flexible and capable of adapting the rehabilitation pathway according to the needs and capacity of the patients will prove effective for subjects with Subjective Memory Complaint or with Mild Cognitive Impairment or with Mild Dementia. The main questions it aims to answer are: Will the RICORDO rehabilitation treatment, lead to an improvement in the global cognitive level? Will the RICORDO rehabilitation treatment lead to improved activation of participants in managing their own health and healthcare? Researchers will compare the multidomain cognitive rehabilitation strategy of RICORDO digital solution, with a standard paper pencil rehabilitation care (usual care). Participants will undergo a comprehensive neuropsychological evaluation immediately before, immediately after and six months after the completion of the rehabilitation program. Both interventions, the experimental and the usual care, will last 5 weeks, with 3 weekly sessions of 45 minutes each and can be done autonomously by the patient at home.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- First submitted
- 3 Jul 2025
- Start date
- Oct 2025
- Primary completion date
- Aug 2027
- Lead sponsor
- Fondazione Don Carlo Gnocchi ETS
- Diseases
- Alzheimer disease
- NCT number
- NCT07064226
What you commit to
- Study type: Interventional
- Planned participants: 102
- From Oct 2025 to the primary completion date, Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of ongoing rehabilitation program at the time of enrollment or in the 3 months prior to enrollment;
Other illness
- Presence of dysmetria or marked auditory/visual or communication disorders preventing the participation to the trial;
Who the study is looking for
- Montreal Cognitive Assessment (MoCA) score \> 17.79;
- Clinical Dementia Rating (CDR) Scale score ≤ 1;
- Education level \> 3 years;
- Age ≥ 65 years;
- Informed consent to participate, confirmed by signing the consent form;
- Availability of a caregiver/study partner able to support the participant;
- Stable pharmacological treatment (past 3 months) with acetylcholinesterase inhibitors, if applicable.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Fondazione Don Carlo Gnocchi ONLUS; Center of Advance Diagnostic and Therapy ( CADiTeR) Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.